Actinium Pharmaceuticals Inc (ATNM)
1.77
+0.01
(+0.57%)
USD |
NYAM |
Nov 05, 09:45
Actinium Pharmaceuticals Max Drawdown (5Y): 95.56% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 95.56% |
| September 30, 2024 | 95.56% |
| August 31, 2024 | 96.67% |
| July 31, 2024 | 96.87% |
| June 30, 2024 | 97.01% |
| May 31, 2024 | 97.29% |
| April 30, 2024 | 97.29% |
| March 31, 2024 | 97.29% |
| February 29, 2024 | 97.29% |
| January 31, 2024 | 97.29% |
| December 31, 2023 | 97.29% |
| November 30, 2023 | 97.29% |
| October 31, 2023 | 97.29% |
| September 30, 2023 | 97.29% |
| August 31, 2023 | 97.29% |
| July 31, 2023 | 97.29% |
| June 30, 2023 | 97.29% |
| May 31, 2023 | 97.29% |
| April 30, 2023 | 97.29% |
| March 31, 2023 | 97.29% |
| February 28, 2023 | 97.38% |
| January 31, 2023 | 97.41% |
| December 31, 2022 | 97.41% |
| November 30, 2022 | 97.41% |
| October 31, 2022 | 97.41% |
| Date | Value |
|---|---|
| September 30, 2022 | 97.41% |
| August 31, 2022 | 97.41% |
| July 31, 2022 | 97.41% |
| June 30, 2022 | 97.41% |
| May 31, 2022 | 97.41% |
| April 30, 2022 | 97.41% |
| March 31, 2022 | 97.41% |
| February 28, 2022 | 97.41% |
| January 31, 2022 | 97.41% |
| December 31, 2021 | 97.41% |
| November 30, 2021 | 97.41% |
| October 31, 2021 | 97.41% |
| September 30, 2021 | 97.41% |
| August 31, 2021 | 97.41% |
| July 31, 2021 | 97.41% |
| June 30, 2021 | 97.41% |
| May 31, 2021 | 97.41% |
| April 30, 2021 | 97.41% |
| March 31, 2021 | 97.41% |
| February 28, 2021 | 97.41% |
| January 31, 2021 | 97.41% |
| December 31, 2020 | 97.41% |
| November 30, 2020 | 97.41% |
| October 31, 2020 | 97.41% |
| September 30, 2020 | 97.41% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
95.56%
Minimum
Sep 2024
97.41%
Maximum
Nov 2019
97.29%
Average
97.41%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Rezolute Inc | 97.31% |
| Moderna Inc | 89.10% |
| Perspective Therapeutics Inc | 91.70% |
| Eli Lilly and Co | 22.48% |
| Cellectar Biosciences Inc | 99.69% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -29.01 |
| Beta (5Y) | 0.1432 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 88.73% |
| Historical Sharpe Ratio (5Y) | -0.3061 |
| Historical Sortino (5Y) | -0.5834 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.49% |